University of Montana Western logo.
Apply Visit More Info

100-Campus Policies / 101.5 Naloxone (NARCAN®) Policy

Policy Information

Date Adopted: 10/05/2023
Date Revised:
Date Reviewed:
Issuing Office:
Student Affairs
Approved By: 
Office of the Chancellor

1. Policy 

It is the policy of the University of Montana Western to train and authorize employees to administer naloxone (NARCAN®) as noted in the procedures. Other university designated individuals may also receive certified training to administer naloxone under the terms outlined in this policy. 

2. Purpose

To establish procedures governing maintenance and administration of naloxone (NARCAN®) by authorized and trained University of Montana Western personnel. The objective is to reduce injuries and fatalities from opiate overdoses. 

3. Definitions

Opioid antagonist means a drug that binds to opioid receptors and blocks or inhibits the effects of opioids acting on those receptors. The term includes, but is not limited to naloxone hydrochloride and any other similarly acting drug approved by the United States Food and Drug Administration.

Naloxone (NARCAN®) is an opioid antagonist.

4. Authority 

5. Responsibility  

Vice Chancellor for Administration and Finance, Dean of Students, Director of Residence Life, and Student Engagement Coordinator.  

Procedures for use of naloxone (NARCAN®)